Matthew Shawn Morris is CEO at Privia Health Group, Inc. (PRVA). They have made 19 open-market trades across 2 companies since 2011, most recently 2026-07-06.
CIK 0001401958
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRVA | 68,188 | $1.5M |
| HS | 44,910 | — |
| Total | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRVA | SELL · 10b5-1 | 2026-07-02 | 2026-07-07 | $27.29 | $3.1M | -0.5% | -18.5% | -24.1% |
| PRVA | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $26.32 | $3.6M | +3.0% | -12.8% | -27.8% |
| PRVA | SELL · 10b5-1 | 2026-06-26 | 2026-06-30 | $25.33 | $3.8M | +7.2% | -8.3% | -23.6% |
| PRVA | SELL · 10b5-1 | 2026-05-01 | 2026-05-05 | $24.99 | $453K | -6.3% | -12.7% | -2.9% |
| PRVA | SELL | 2026-02-26 | 2026-03-02 | $25.00 | $608K | -8.0% | -10.8% | -9.8% |
| PRVA | SELL · 10b5-1 | 2025-12-12 | 2025-12-16 | $25.01 | $683K | +0.7% | +0.7% | -7.3% |
| PRVA | SELL | 2025-04-30 | 2025-05-02 | $23.33 | $481K | +4.5% | -1.8% | -16.1% |
| PRVA | SELL | 2024-04-30 | 2024-05-02 | $18.42 | $407K | -4.1% | -7.9% | +10.2% |
| PRVA | SELL · 10b5-1 | 2023-06-12 | 2023-06-14 | $28.53 | $19.2M | -6.7% | -6.4% | -13.0% |
| PRVA | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $27.76 | $1.6M | +7.5% | +1.4% | +13.1% |
| PRVA | SELL · 10b5-1 | 2023-04-11 | 2023-04-13 | $28.11 | $1.4M | -2.1% | -1.2% | -7.9% |
| PRVA | SELL · 10b5-1 | 2023-04-04 | 2023-04-05 | $28.06 | $397K | -6.6% | +5.0% | -7.1% |
| PRVA | SELL | 2023-03-06 | 2023-03-08 | $28.41 | $4.6M | -5.4% | -2.2% | -13.9% |
| PRVA | SELL · 10b5-1 | 2022-11-15 | 2022-11-17 | $28.19 | $34K | +0.1% | -2.6% | +14.9% |
| PRVA | SELL | 2022-11-03 | 2022-11-07 | $29.65 | $1.8M | -16.4% | -20.0% | -8.5% |
| PRVA | SELL | 2022-10-13 | 2022-10-17 | $34.33 | $3.0M | -4.3% | -30.2% | -22.3% |
| PRVA | SELL | 2022-10-03 | 2022-10-05 | $34.73 | $3.4M | -6.1% | -20.6% | -38.0% |
| PRVA | SELL | 2022-09-21 | 2022-09-23 | $35.97 | $804K | +5.7% | -5.2% | -30.2% |
| PRVA | SELL | 2022-09-06 | 2022-09-08 | $39.42 | $5.2M | -12.1% | -19.0% | -46.6% |
| PRVA | SELL | 2022-08-25 | 2022-08-29 | $41.03 | $10.3M | +6.6% | -8.6% | -41.4% |
| PRVA | SELL | 2022-08-15 | 2022-08-17 | $35.79 | $9.7M | +8.0% | +10.8% | -24.8% |
| PRVA | SELL | 2022-07-19 | 2022-07-21 | $34.09 | $15.9M | +5.3% | +15.3% | -9.9% |
| PRVA | SELL | 2022-07-07 | 2022-07-11 | $33.64 | $10.7M | +11.7% | +11.5% | +4.8% |
| PRVA | SELL | 2022-06-22 | 2022-06-24 | $29.29 | $8.6M | +13.6% | +23.6% | +17.7% |
| PRVA | SELL | 2021-11-23 | 2021-11-26 | $27.70 | $18.8M | -6.0% | +5.2% | -2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.